Seizure reduction is a prognostic marker in low-grade glioma patients treated with temozolomide

Author(s):
Koekkoek, J.A.F.; Dirven, L.; Heimans, J.J.; Postma, T.J.; Vos, M.J.; Reijneveld, J.C.; Taphoorn, M.J.B.
Published
2016
Publication type
Article / Letter to editor
SeizuresChemotherapyTemozolomidePrimary brain tumorGlioma
Date issued
2016-01-31
Language
English
Is part of
Journal of Neuro-Oncology (2016), Vol. 126, no. 2, p. 347-354
hdl
1887/112631
doi
10.1007/s11060-015-1975-y